Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Return on Equity (2016 - 2025)

BioCorRx (BICX) has disclosed Return on Equity for 15 consecutive years, with 0.48% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 5.0% to 0.48% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.48% through Dec 2025, up 5.0% year-over-year, with the annual reading at 0.3% for FY2025, 17.0% down from the prior year.
  • Return on Equity hit 0.48% in Q4 2025 for BioCorRx, down from 30.27% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 30.27% in Q1 2025 to a low of 0.38% in Q1 2024.
  • Historically, Return on Equity has averaged 2.26% across 5 years, with a median of 0.54% in 2022.
  • Biggest five-year swings in Return on Equity: crashed -244bps in 2021 and later skyrocketed 2989bps in 2025.
  • Year by year, Return on Equity stood at 0.82% in 2021, then plummeted by -31bps to 0.57% in 2022, then tumbled by -31bps to 0.39% in 2023, then grew by 10bps to 0.43% in 2024, then increased by 11bps to 0.48% in 2025.
  • Business Quant data shows Return on Equity for BICX at 0.48% in Q4 2025, 30.27% in Q1 2025, and 0.43% in Q4 2024.